Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 835 M857 M911 M925 M895 M937 M 3.67 B Research & development 663 M660 M666 M690 M705 M747 M 2.81 B Operating income 39 M248 M259 M175 M338 M313 M 1.08 B Non-Operating Income, Total 64 M56 M79 M89 M17 M14 M 199 M Interest expense, net of interest capitalized 29 M29 M29 M27 M26 M27 M 109 M Non-Operating Income, excl. Interest Expenses 64 M59 M26 M-1 M0-15 M 10 M Unusual income/expense 0-3 M24 M63 M-9 M2 M 80 M Pretax income 103 M304 M338 M264 M355 M327 M 1.28 B Equity in earnings —————— — Taxes 35 M76 M86 M119 M133 M-305 M 33 M Non-controlling/minority interest —————— — After tax other income/expense -47 M-34 M-39 M45 M-5 M7 M 8 M Net income before discontinued operations 68 M228 M252 M145 M222 M632 M 1.25 B Discontinued operations —————— — Net income 68 M228 M252 M145 M222 M632 M 1.25 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 68 M228 M252 M145 M222 M632 M 1.25 B Basic earnings per share (Basic EPS) 0.250.860.950.550.872.58 4.95 Diluted earnings per share (Diluted EPS) 0.250.840.940.560.872.57 4.94 Average basic shares outstanding 266.52 M266.78 M265.87 M265.1 M253.89 M245.18 M — Diluted shares outstanding 270.3 M270.18 M268.63 M268.12 M254.31 M246.31 M — EBITDA 187 M392 M415 M321 M513 M489 M 1.74 B EBIT 39 M248 M259 M175 M338 M313 M 1.08 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 148 M144 M156 M146 M175 M176 M 653 M